+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bronchodilators Market by Mechanism Of Action, Product Type, Indication, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030- Product Image
Bronchodilators Market by Mechanism Of Action, Product Type, Indication, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030- Product Image
Sale

Bronchodilators Market by Mechanism Of Action, Product Type, Indication, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6084105
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bronchodilators market is experiencing robust transformation as patient-centric innovations, digital health integration, and evolving care models reshape how respiratory conditions are managed. Decision-makers seeking actionable direction will find this detailed analysis essential for navigating market intricacies and capturing emerging value.

Market Snapshot: Bronchodilators Market Growth & Trends

The bronchodilators market grew from USD 19.20 billion in 2024 to USD 20.42 billion in 2025. The sector is projected to expand at a CAGR of 6.23%, reaching USD 27.61 billion by 2030. This upward momentum is propelled by rising respiratory disease burdens, aging populations, and heightened focus on air quality and disease prevention.

Scope & Segmentation of the Bronchodilators Market

  • Mechanism of Action: Anticholinergics, Beta-2 agonists, and Combination agents dominate therapeutic approaches, influencing strategic development and clinical preference.
  • Product Type: The market includes long-acting and short-acting formulations, each tailored to different treatment windows and patient needs.
  • Indication: Primary segments are asthma and COPD, with growth in both chronic and acute management settings.
  • Route of Administration: Delivery routes include inhalation (with dry powder inhalers, metered-dose inhalers, soft mist inhalers), injectable, nebulization (jet and ultrasonic), and oral options.
  • Distribution Channel: Hospital pharmacy, online pharmacy, and retail pharmacy underpin access, shaped by reimbursement and patient engagement models.
  • End User: Clinics, home care, and hospitals, reflecting trends toward decentralized and home-based care.
  • Geographic Coverage: Americas (including U.S., Canada, Brazil, Mexico, Argentina), Europe, Middle East & Africa (from the UK to South Africa, UAE, and beyond), and Asia-Pacific (including China, India, Australia, Japan, and other dynamic economies).
  • Key Technologies: Smart inhalers, advanced delivery mechanisms, and digital therapeutics support precision therapy and adherence monitoring.
  • Leading Companies: GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novartis, Teva, Viatris, Chiesi Farmaceutici, Cipla, Sunovion Pharmaceuticals, Hikma Pharmaceuticals.

Key Takeaways for Senior Decision-Makers

  • Innovative delivery technologies, such as soft mist inhalers and integrated digital tools, are redefining standards in respiratory care, driving preference and improving patient adherence.
  • Combination therapies combining muscarinic antagonists and beta-2 agonists are gaining clinical traction for their synergistic efficacy in complex patient populations.
  • Market dynamics reveal a distinct acceleration in value-based care, with stakeholders increasingly focused on demonstrating real-world outcomes and cost-effectiveness.
  • Regional nuances matter: mature markets benefit from strong reimbursement infrastructure, while emerging regions prioritize accessibility through generics, local production, and government partnerships.
  • Strategic alliances, mergers, and cross-sector collaborations foster competitive differentiation by leveraging cross-disciplinary expertise and enhancing market access.
  • Operational agility in R&D, supply chain, and commercialization is crucial as competitive and regulatory pressures intensify across global markets.

Tariff Impact: Navigating U.S. Market Challenges

The 2025 U.S. tariff landscape introduces supply chain pressures, increasing costs for internationally sourced active pharmaceutical ingredients and finished products. Manufacturers are exploring nearshoring and expanding domestic capabilities to reduce tariff risk and maintain consistent supply. These shifts drive new partnerships for co-development and manufacturing, while distributors and healthcare services adapt pricing strategies in response. Proactive risk management, diversified sourcing, and improved supply chain transparency will remain vital as schedules and trade policy evolve.

Research Methodology & Data Sources

This analysis relies on primary research with clinicians, payers, and supply chain experts, using structured interviews and targeted surveys. Secondary sources include peer-reviewed journals, regulatory filings, industry white papers, and financial disclosures, with rigorous data triangulation to validate trends and minimize bias. Quantitative modeling and thematic analysis are applied to ensure accuracy and actionable insights.

Why This Report Matters

  • Equips leadership with a strategic roadmap for investment, innovation, and market entry based on robust analysis of industry trends.
  • Offers actionable insights for harnessing technology, optimizing supply chains, and aligning commercialization with evolving payer and patient demands.
  • Assists in identifying targeted opportunities across mechanisms, regions, and end-user segments to drive sustainable growth and portfolio differentiation.

Conclusion

The bronchodilators market is entering a phase of dynamic evolution, driven by innovation, regulatory shifts, and increased demand for value-based respiratory care. This report empowers senior decision-makers to respond decisively, drive growth, and confidently steer competitive strategy.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bronchodilators Market, by Mechanism Of Action
8.1. Introduction
8.2. Anticholinergics
8.2.1. Long-Acting Muscarinic Antagonists
8.2.2. Short-Acting Muscarinic Antagonists
8.3. Beta-2 Agonists
8.3.1. Long-Acting Beta-2 Agonists
8.3.2. Short-Acting Beta-2 Agonists
8.4. Combination Agents
8.4.1. ICS/LABA Combinations
8.4.2. LABA/LAMA Combinations
9. Bronchodilators Market, by Product Type
9.1. Introduction
9.2. Long-Acting
9.3. Short-Acting
10. Bronchodilators Market, by Indication
10.1. Introduction
10.2. Asthma
10.3. COPD
11. Bronchodilators Market, by Route Of Administration
11.1. Introduction
11.2. Inhalation
11.2.1. Dry Powder Inhaler
11.2.2. Metered-Dose Inhaler
11.2.3. Soft Mist Inhaler
11.3. Injectable
11.4. Nebulization
11.4.1. Jet Nebulization
11.4.2. Ultrasonic Nebulization
11.5. Oral
12. Bronchodilators Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Bronchodilators Market, by End User
13.1. Introduction
13.2. Clinics
13.3. Home Care
13.4. Hospitals
14. Americas Bronchodilators Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Bronchodilators Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Bronchodilators Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. GlaxoSmithKline plc
17.3.2. AstraZeneca plc
17.3.3. Boehringer Ingelheim International GmbH
17.3.4. Novartis AG
17.3.5. Teva Pharmaceutical Industries Ltd
17.3.6. Viatris Inc.
17.3.7. Chiesi Farmaceutici S.p.A
17.3.8. Cipla Limited
17.3.9. Sunovion Pharmaceuticals Inc.
17.3.10. Hikma Pharmaceuticals PLC
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BRONCHODILATORS MARKET MULTI-CURRENCY
FIGURE 2. BRONCHODILATORS MARKET MULTI-LANGUAGE
FIGURE 3. BRONCHODILATORS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BRONCHODILATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BRONCHODILATORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRONCHODILATORS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRONCHODILATORS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BRONCHODILATORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BRONCHODILATORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BRONCHODILATORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BRONCHODILATORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BRONCHODILATORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BRONCHODILATORS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BRONCHODILATORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRONCHODILATORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRONCHODILATORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BRONCHODILATORS MARKET SIZE, BY LONG-ACTING MUSCARINIC ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BRONCHODILATORS MARKET SIZE, BY SHORT-ACTING MUSCARINIC ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BRONCHODILATORS MARKET SIZE, BY LONG-ACTING BETA-2 AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BRONCHODILATORS MARKET SIZE, BY SHORT-ACTING BETA-2 AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BRONCHODILATORS MARKET SIZE, BY ICS/LABA COMBINATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BRONCHODILATORS MARKET SIZE, BY LABA/LAMA COMBINATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BRONCHODILATORS MARKET SIZE, BY LONG-ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BRONCHODILATORS MARKET SIZE, BY SHORT-ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BRONCHODILATORS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BRONCHODILATORS MARKET SIZE, BY COPD, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BRONCHODILATORS MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BRONCHODILATORS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BRONCHODILATORS MARKET SIZE, BY METERED-DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BRONCHODILATORS MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BRONCHODILATORS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BRONCHODILATORS MARKET SIZE, BY JET NEBULIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BRONCHODILATORS MARKET SIZE, BY ULTRASONIC NEBULIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BRONCHODILATORS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BRONCHODILATORS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BRONCHODILATORS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BRONCHODILATORS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BRONCHODILATORS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BRONCHODILATORS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BRONCHODILATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BRONCHODILATORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. CANADA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 70. CANADA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 71. CANADA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 72. CANADA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 73. CANADA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. CANADA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 77. CANADA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 78. CANADA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. CANADA BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. MEXICO BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 81. MEXICO BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 83. MEXICO BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. MEXICO BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. MEXICO BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA BRONCHODILATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. GERMANY BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 137. GERMANY BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 138. GERMANY BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 139. GERMANY BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 140. GERMANY BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. GERMANY BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. GERMANY BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. GERMANY BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 144. GERMANY BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 145. GERMANY BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. GERMANY BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 148. FRANCE BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 149. FRANCE BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 150. FRANCE BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 151. FRANCE BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. FRANCE BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 153. FRANCE BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. FRANCE BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 155. FRANCE BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 156. FRANCE BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. FRANCE BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. ITALY BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 170. ITALY BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 171. ITALY BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 172. ITALY BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 173. ITALY BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. ITALY BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. ITALY BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. ITALY BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 177. ITALY BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 178. ITALY BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. ITALY BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. SPAIN BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 181. SPAIN BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 182. SPAIN BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 183. SPAIN BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 184. SPAIN BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. SPAIN BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. SPAIN BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. SPAIN BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 188. SPAIN BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 189. SPAIN BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. SPAIN BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. DENMARK BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 225. DENMARK BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 226. DENMARK BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 227. DENMARK BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 228. DENMARK BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. DENMARK BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 230. DENMARK BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. DENMARK BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 232. DENMARK BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 233. DENMARK BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. DENMARK BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. QATAR BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 247. QATAR BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 248. QATAR BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 249. QATAR BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 250. QATAR BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. QATAR BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 252. QATAR BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 253. QATAR BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 254. QATAR BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 255. QATAR BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. QATAR BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. FINLAND BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 258. FINLAND BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 259. FINLAND BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 260. FINLAND BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 261. FINLAND BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. FINLAND BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 263. FINLAND BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 264. FINLAND BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 265. FINLAND BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 266. FINLAND BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. FINLAND BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. SWEDEN BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 269. SWEDEN BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 270. SWEDEN BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 271. SWEDEN BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. NIGERIA BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. EGYPT BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 291. EGYPT BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 292. EGYPT BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 293. EGYPT BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 294. EGYPT BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. EGYPT BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 296. EGYPT BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 297. EGYPT BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 298. EGYPT BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 299. EGYPT BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. EGYPT BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. TURKEY BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 302. TURKEY BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 303. TURKEY BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 304. TURKEY BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 305. TURKEY BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. TURKEY BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 307. TURKEY BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 308. TURKEY BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 309. TURKEY BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 310. TURKEY BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. TURKEY BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. ISRAEL BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 313. ISRAEL BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 314. ISRAEL BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 315. ISRAEL BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 316. ISRAEL BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. ISRAEL BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 318. ISRAEL BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 319. ISRAEL BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 320. ISRAEL BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 321. ISRAEL BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. ISRAEL BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. NORWAY BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 324. NORWAY BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 325. NORWAY BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 326. NORWAY BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 327. NORWAY BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 328. NORWAY BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 329. NORWAY BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 330. NORWAY BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 331. NORWAY BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 332. NORWAY BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 333. NORWAY BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. POLAND BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 335. POLAND BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 336. POLAND BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 337. POLAND BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 338. POLAND BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 339. POLAND BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 340. POLAND BRONCHODILATORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 341. POLAND BRONCHODILATORS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 342. POLAND BRONCHODILATORS MARKET SIZE, BY NEBULIZATION, 2018-2030 (USD MILLION)
TABLE 343. POLAND BRONCHODILATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 344. POLAND BRONCHODILATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 345. SWITZERLAND BRONCHODILATORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 346. SWITZERLAND BRONCHODILATORS MARKET SIZE, BY ANTICHOLINERGICS, 2018-2030 (USD MILLION)
TABLE 347. SWITZERLAND BRONCHODILATORS MARKET SIZE, BY BETA-2 AGONISTS, 2018-2030 (USD MILLION)
TABLE 348. SWITZERLAND BRONCHODILATORS MARKET SIZE, BY COMBINATION AGENTS, 2018-2030 (USD MILLION)
TABLE 349. SWITZERLAND BRONCHODILATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 350. SWITZERLAND BRONCHODILATORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bronchodilators market report include:
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc.
  • Chiesi Farmaceutici S.p.A
  • Cipla Limited
  • Sunovion Pharmaceuticals Inc.
  • Hikma Pharmaceuticals PLC

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 20.42 Billion
Forecasted Market Value ( USD ) by 2030 $ 27.61 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bronchodilators - Global Strategic Business Report - Product Image

Bronchodilators - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Bronchodilators Market Report 2025 - Product Image

Bronchodilators Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Bronchodilators Market Report by Indication, Drug Type, Route of Administration, and Region 2024-2032 - Product Image

Bronchodilators Market Report by Indication, Drug Type, Route of Administration, and Region 2024-2032

  • Report
  • 135 Pages
  • Global
From
2025 Global Forecast for Bronchodilator Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Bronchodilator Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Inhalers & Nebulizers Market by Device Type, Therapeutic Class, Distribution Channel, End User, Indication - Global Forecast to 2030 - Product Image

Inhalers & Nebulizers Market by Device Type, Therapeutic Class, Distribution Channel, End User, Indication - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From

About the Bronchodilator Market

The Bronchodilator market is composed of inhalers and nebulisers, both of which are used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or spray. Nebulisers are larger machines that convert liquid medication into a fine mist that can be inhaled. Both inhalers and nebulisers are used to deliver bronchodilators, which are medications that relax the muscles in the airways and make it easier to breathe. Inhalers are the most commonly used form of bronchodilator delivery, as they are more convenient and cost-effective than nebulisers. Inhalers come in a variety of forms, including metered dose inhalers (MDIs), dry powder inhalers (DPIs), and soft mist inhalers (SMIs). Nebulisers are typically used for more severe cases of respiratory conditions, as they can deliver a higher dose of medication than inhalers. Some of the companies in the Bronchodilator market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Merck. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.